Source: Annual Congress 2008 - Issues in the management of COPD in the community
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. H. Lam, R. E. Jordan, M. R. Miller, C. Q. Jiang, T. H. Lam, K. K. Cheng, P. Adab (Birmingham, United Kingdom; Guangzhou, Hong Kong, China). Respiratory symptoms as predictor of impairment in COPD: the Guangzhou Biobank cohort study. Eur Respir J 2008; 32: Suppl. 52, 3516

Member's Comments

No comment yet.

Related content which might interest you: Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Work-related COPD risk in the population-based UK Biobank cohort study Source: International Congress 2015 – Occupational factors in COPD and bronchitis Year: 2015 Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Respiratory symptoms in COPD: a comparison between the UK and China Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD Year: 2008 Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Introducing the UK Biobank cohort study – what‘s in it for respiratory disease? Source: Eur Respir J 2005; 26: Suppl. 49, 597s Year: 2005 Lung function and respiratory symptoms as predictors of mortality: The HUNT study Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012 Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study Source: Eur Respir J 2014; 43: 1289-1297 Year: 2014 Undiagnosed COPD: who is at risk, and does it matter? The Guangzhou biobank cohort study (GBCS) Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009 Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Long-term survivalaccording to Czech clinical phenotypes of COPD- Czech multicentre research database of severe COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Childhood wheeze – A risk factor for COPD? A 50-year cohort study Source: International Congress 2015 – Respiratory health across the life course Year: 2015 Air pollution, lung function and COPD: results from the population-based UK Biobank study Source: Eur Respir J, 54 (1) 1802140; 10.1183/13993003.02140-2018 Year: 2019 CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Lung function (LF) decline and hospitalization in subjects with the asthma-COPD overlap syndrome Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Respiratory parameters predict mortality in COPD patients - data from the Czech multicentre research database of severe COPD. Source: International Congress 2017 – Markers of COPD progression Year: 2017 Association between functionality and respiratory impairment after hospitalization for COVID-19: a cohort study Source: Virtual Congress 2021 – COVID-19: insights from respiratory physiotherapists Year: 2021 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Prevalence of co-morbidities in a Hellenic COPD population (COMPACT study) Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014